Understanding Community-Acquired Pneumonia and Treatment Options
Title: Understanding Community-Acquired Pneumonia and Treatment Options
Date: Tuesday, January 9, 2018
Time: 1 p.m. ET
Presenters: Thomas M. File, Jr., MD
Unless otherwise noted, P.A.C.E.™ accreditation will expire six months after the live webinar.
Faster Treatment of Community-Acquired Pneumonia Therapy
Join us for a complimentary, P.A.C.E.-accredited webinar that will focus on better understanding community-acquired pneumonia (CAP) and the advantages of using rapid diagnostic testing.
Current treatment practices expose patients to more antimicrobials than necessary, eradicate a significant proportion of organisms belonging to the normal host flora, and select for antimicrobial resistant pathogens.
With advances in diagnostic tests, it is now possible to provide early treatment with a focused antimicrobial regimen that targets the identified pathogens. Ultimately, this will permit a selection of agents against a specific pathogen and substantially reduce exposure of individuals and hospitals to antimicrobial agents.
Learning Objectives
This webinar will help you:
- Identify the differences between empirical and pathogen-directed therapy for CAP
- Analyze pathogens responsible for CAP
- Review the diagnostic and treatment options available for CAP
- Identify the advantages of rapid diagnostic methods for CAP
This webinar is produced by Whitehat Communications, a provider of continuing education programs in clinical laboratory sciences that has been approved by the ASCLS P.A.C.E Program. One P.A.C.E. credit hour will be provided for this complimentary, basic-level program. Unless otherwise noted, P.A.C.E accreditation will expire six months after the live webinar.
Presenter
Thomas M. File, Jr., MD, MSc., MACP, FIDSA, FCCP
Dr. File is Chief of the Infectious Disease Service and Director of HIV Research at Summa Health System in Akron, Ohio. He also serves as a Professor of Internal Medicine and Master Teacher at Northeast Ohio University College of Medicine. He is Fellow of the American College of Physicians, the Infectious Diseases Society of America, and the American College of Chest Physicians, and is on the Board of Directors of the National Foundation for Infectious Diseases.
Primary research interests that Dr. File has pursued include community-acquired respiratory tract infections, bacterial resistance in respiratory infections, infections in patients with diabetes, and evaluation of new antimicrobial agents. A frequent lecturer both nationally and internationally, Dr. File has published more than 200 articles, abstracts, and textbook chapters, focusing on the diagnosis, etiology, and treatment of infectious diseases, especially on respiratory tract infections. He recently co-edited Community-Acquired Respiratory Infections (2003, published by Marcel Dekker, NY). In addition, he currently serves on the Editorial Board of the Journal of Respiratory Disease and is Editor-in-Chief of Infectious Diseases in Clinical Practice.